Get startedLog in
    Picture of Kissei Pharmaceutical Co logo

    4547 — Kissei Pharmaceutical Co Cashflow Statement

    0.000.00%
    jp flag iconLast trade - 00:00
    HealthcareBalancedMid CapNeutral
    Balance sheetIncome statementCashflow
    Subscribe to view all data

    Annual cashflow statement for Kissei Pharmaceutical Co, fiscal year end - March 31st, JPY millions except per share, conversion factor applied.

    2020
    March 31st
    2021
    March 31st
    2022
    March 31st
    2023
    March 31st
    2024
    March 31st
    Period Length:12 M12 M12 M12 M12 M
    Source:YuhoYuhoYuhoYuhoYuho
    Standards:
    JAS
    JAS
    JAS
    JAS
    JAS
    Status:FinalFinalFinalFinalFinal
    Net Income/Starting Line4,6307,47616,50713,68014,449
    Depreciation
    Non-Cash Items-2,742-5,979-18,120-14,596-10,320
    Unusual Items
    Other Non-Cash Items
    Changes in Working Capital9,483-7,188-584-9,873-10,061
    Change in Accounts Receivable
    Change in Inventories
    Change in Other Assets
    Change in Accounts Payable
    Change in Other Liabilities
    Other Operating Cash Flow
    Cash from Operating Activities13,933-2,5431,533-6,680-1,678
    Capital Expenditures-1,302-1,485-1,919-2,547-1,833
    Purchase of Fixed Assets
    Purchase / Acquisition of Intangibles
    Other Investing Cash Flow Items1,792-7,84412,6958,54810,523
    Sale of Fixed Assets
    Sale/Maturity of Investment
    Purchase of Investments
    Other Investing Cash Flow
    Cash from Investing Activities490-9,32910,7766,0018,690
    Financing Cash Flow Items-2-2-2-2-1
    Other Financing Cash Flow
    Total Cash Dividends Paid
    Net Issuance / Retirement of Stock
    Net Issuance / Retirement of Debt
    Cash from Financing Activities-4,419-4,000-2,756-3,420-10,006
    Foreign Exchange Effects
    Beginning Cash Balance
    Ending Cash Balance
    Net Change in Cash10,004-15,8729,557-4,120-2,997